Related Experiment Video
Updated: May 9, 2026

Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors
Published on: February 9, 2024
Gastroenteropancreatic endocrine tumors
Alan Meeker1, Christopher Heaphy1
1The Johns Hopkins University School of Medicine, Department of Pathology, Bond Street Research Annex Bldg., Room B300, 411 North Caroline Street, Baltimore, MD 21231, United States.
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare cancers. Recent advances in genetics and epigenetics research offer hope for new diagnostic and therapeutic strategies for GEP-NETs.
Area of Science:
- Oncology
- Genetics
- Epigenetics
Background:
- Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are uncommon, representing about 0.5% of human cancers.
- Despite often indolent courses, GEP-NETs can progress lethally, yet remain understudied due to rarity and technical challenges.
- Limited diagnostic, prognostic, and predictive biomarkers hinder effective management of GEP-NETs.
Purpose of the Study:
- To review the current understanding of the genetics and epigenetics of GEP-NETs.
- To highlight how recent technological advancements are illuminating the molecular underpinnings of these tumors.
- To discuss the potential of
- omics
- studies in advancing GEP-NET research.
Main Methods:
- Literature review focusing on genetics and epigenetics of GEP-NETs.
- Analysis of recent technological advancements and their application to GEP-NET research.
- Synthesis of findings from
- omics
- studies relevant to GEP-NETs.
Main Results:
- Significant technological progress in genetics and epigenetics has yielded new insights into GEP-NET molecular abnormalities.
- The review consolidates current knowledge on the genetic and epigenetic landscape of GEP-NETs.
- Emerging
- omics
- data are beginning to reveal the complex molecular basis of GEP-NET development and progression.
Conclusions:
- Future
- omics
- studies are expected to yield novel diagnostic and prognostic biomarkers for GEP-NETs.
- Advancements in understanding GEP-NET genetics and epigenetics will inform the development of improved pre-clinical models.
- This research trajectory holds promise for identifying new therapeutic targets to improve outcomes for GEP-NET patients.
Related Concept Videos
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction
Pancreas
The broad head of the pancreas lies within the loop formed by the duodenum, while its slender body reaches towards the spleen. The tail of the pancreas is short and...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Acute Pancreatitis I: Introduction